Healthcare/biotech – FastNews

WuXi AppTec has recently come under fire from U.S. politicians who want to ban government-backed projects from buying its services, causing the stock to lose about half of its value this year.

FAST NEWS: BlackRock boosts stake in battered WuXi AppTec

The latest: Asset management company BlackRock Inc. purchased 618,000 Hong Kong-listed shares of WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) on March 26, raising its stake in the drug outsourcing services company from…
2359.HK 603259.SHG
Vaccine maker AIM Vaccine said on Monday it expects to report a net loss of 1.25 billion yuan to 1.38 billion yuan for last year, roughly quadruple its loss from 2022.

FAST NEWS: AIM Vaccine’s loss balloons

The latest: Vaccine maker AIM Vaccine Co. Ltd. (6660.HK) said on Monday it expects to report a net loss of 1.25 billion yuan ($174 million) to 1.38 billion yuan for last…
6660.HK

Recent Articles

RELATED ARTICLES

  1. WuXi Biologics is spinning off its WuXi XDC ADS unit
    WuXi Biologics hatches new baby with ADC drug unit IPO
    2269.HK
  2. FAST NEWS: WuXi XDC kicks off IPO with star cornerstone investors
    2269.HK
  3. WuXi Bio prescribes share buyback to relieve revenue pain
    2269.HK
  4. Potential U.S. targeting casts shadow over WuXi AppTec family
    2359.HK 603259.SHG
  5. FAST NEWS: WuXi Biologics boosts new projects target
    2269.HK
  6. FAST NEWS: JPMorgan boosts WuXi AppTec stake
    2359.HK 603259.SHG
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo File-alt

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners